9 studies found for:    Open Studies | "Glucosephosphate Dehydrogenase Deficiency"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Glucosephosphate Dehydrogenase Deficiency"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Diet Challenge in G6PD Deficient Egyptian Children: A One- Year Prospective Single Center Study With Genotype - Phenotype Correlation
Condition: Glucose-6-Phosphate Dehydrogenase Deficiency
Intervention: Dietary Supplement: non- fava beans
2 Recruiting Safety and Tolerability of Low Dose Primaquine
Conditions: Malaria, Falciparum;   G6PD Deficiency
Interventions: Drug: Dihydroartemisinin piperaquine (DHA PP);   Drug: Primaquine
3 Recruiting Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency
Condition: Neonatal Hyperbilirubinemia
Intervention: Drug: Yinzhihuang Oral Liquid
4 Not yet recruiting Validation of New G6PD Point of Care Tests Against Gold Standard Quantitative
Conditions: Validation;   Biosensors;   Genotyping
Intervention:
5 Recruiting Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia
Condition: Malaria
Interventions: Drug: Dihydroartemisinin-piperaquine (DHAP) administered to G6PD deficient individuals;   Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.25 mg/kg primaquine administered to G6PD deficient individuals;   Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.4 mg/kg primaquine administered to G6PD deficient individuals;   Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.25 mg/kg primaquine administered to G6PD normal individuals;   Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.4 mg/kg primaquine administered to G6PD normal individuals
6 Recruiting A Study to Assess Current Standard Malaria Treatment Guidelines in the Republic of the Sudan
Condition: Malaria
Interventions: Drug: ASP;   Drug: SDPQ;   Drug: 14DPQ;   Drug: 14DPQ on Day 42
7 Not yet recruiting A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria
Condition: Malaria, Vivax
Interventions: Drug: Tafenoquine;   Drug: Chloroquine
8 Recruiting The Role of Ursodeoxycholic Acid in Treatment of Gallstones in Hemolytic Disorders
Conditions: Hemolytic Disorders;   Gallstones
Intervention: Drug: Ursodeoxycholic Acid
9 Recruiting Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria
Condition: Malaria, Vivax
Interventions: Drug: Tafenoquine;   Drug: Tafenoquine Placebo;   Drug: Chloroquine;   Drug: Primaquine;   Drug: Primaquine Placebo

Indicates status has not been verified in more than two years